Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

SYMPOSIUM
[View FULLTEXT] [Download PDF
 
Year : 2003  |  Volume : 49  |  Issue : 1  |  Page : 50-4  

Cutaneous leishmaniasis: an overview.

NC Hepburn 
 Consultant Dermatologist, Lincoln County Hospital Lincoln LN2 5QY United Kingdom.

Correspondence Address:
N C Hepburn
Consultant Dermatologist, Lincoln County Hospital Lincoln LN2 5QY United Kingdom.

Leishmaniasis is a major world health problem, which is increasing in incidence. In Northern Europe it is seen in travellers returning from endemic areas. The protozoa is transmitted by sandflies and may produce a variety of clinical syndromes varying from a simple ulcer to fatal systemic disease. This review considers the management of simple cutaneous leishmaniasis. Patients usually have a single ulcer that may heal spontaneously, requiring only topical, or no treatment at all. Lesions caused by Leishmania braziliensis may evolve into the mucocutaneous form, «SQ»espundia«SQ», and should be treated with systemic antimony. Sodium stibogluconate 20mg/kg/day i.v. for 20 days is the appropriate first line treatment in these cases. Although it may cause transient bone marrow suppression, liver damage, a chemical pancreatitis, and disturbances in the electrocardiogram, it appears safe. The success of treatment should be assessed 6 weeks after it has been completed and patients should be followed up for 6 months.


How to cite this article:
Hepburn N C. Cutaneous leishmaniasis: an overview. J Postgrad Med 2003;49:50-4


How to cite this URL:
Hepburn N C. Cutaneous leishmaniasis: an overview. J Postgrad Med [serial online] 2003 [cited 2020 Oct 30 ];49:50-4
Available from: https://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=1;spage=50;epage=4;aulast=Hepburn;type=0


 
Friday, October 30, 2020
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer